Children's Smiles Became My Conviction
Ask him why he continues this work, and his answer is fixed: "The smiles of the children, their teams, and their parents — and repaying the companies that sponsor us." A designer from Hiroshima who lost his business to COVID arrived at "children's smiles" — a landing I find beautiful.
His dreams extend along that line: growing the tournament nationwide; supporting players' development and even their second careers; showcasing each host region's specialties to raise the region's own value; and someday delivering all of it to children around the world.
All six of our executives landed on "smiles" in their separate essays. In his case, the smiles have concrete faces — the children running on the pitch. Perhaps conviction is not an abstract word, but the face of someone you cannot forget. Whose face appears in yours? 38・39 回+第 61 回〜第 100 回)
What do you work for?
— Tomoki Nagano, Chairman & CEO, INSTINCT BIO TECHNICAL COMPANY (NASDAQ: BIOT)
About the Company
The Nasdaq-listed company where the author serves as Chairman.
- Business →Stem-cell cosmetics R&D, OEM/ODM manufacturing, and in-house brands
- Investor Relations →BIOT stock price, SEC filings, and governance
- Company & Governance →Company profile and leadership
This series reflects the personal views of the author. It is not an earnings forecast, a valuation of any security, or a solicitation to invest.